Welcome to Medications.com

Watson Pharmaceuticals Turns To Profit In Q4; Adj. EPS Tops ... - RTT News

... related to the loss of revenue from oxycodone HCI controlled-release tablets. This was offset by new product launches in 2007 of bupropion hydrochloride ...

http://www.rttnews.com/sp/todayst... | Posted: Wed Feb 20 09:39:53 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea